Medtronic’s Glucose Management System Gets NICE Recommendation
This article was originally published in Clinica
Executive Summary
Medtronic scored a victory over rival Johnson & Johnson/Animas in the UK market on Feb. 12, with the release of a new guidance on continuous glucose management (CGM) systems from the UK’s National Institute for Health and Care Excellence.